Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

NextMeds Tirzepatide Review: Cost, an Unconfirmed LegitScript Claim & Honest Verdict (2026)

NextMeds: $109 a month for compounded tirzepatide at every dose, visits and dietitian included, pharmacies named — plus an FDA letter to its parent company.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

FDA warning letter
FDA issued Trinity HealthCare Supply, LLC dba altRx a warning letter in June 2026 (False & Misleading Claims/Misbranded (Telehealth)). Read the letter on FDA’s own warning-letter database.

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

RxSpan MD

Physician-founded, LegitScript-certified, and one of the few programs that names every 503A pharmacy it uses.

$329/mo injection (month-to-month)

Check RxSpan MD availability

NextMeds charges $109 a month for compounded tirzepatide on a month-to-month plan — $95 a month on a 12-month plan — the same at every dose, with the telehealth visits, a 1:1 care coach and a registered dietitian bundled in (price verified August 28, 2026, during a summer promotion; a separate fee may apply at checkout). It names its compounding pharmacies — Foothills Pharmacy, RedRock, Health Warehouse, Precision Medicine and Triad Rx appear on its site — which most programs will not do. Two things to know before you pay: its "LegitScript approval" links to a generic directory search rather than a seal, and NextMeds is a trading name of Trinity HealthCare Supply, LLC — the same company that operates altRx — to which the FDA addressed a June 2026 warning letter about telehealth marketing claims. That letter is disclosed on this page; it does not change what NextMeds charges or dispenses.

An unconfirmed LegitScript claim

Worth flagging directly,: NextMeds shows a LegitScript "approval" mention, but the link behind it points only to a generic directory search rather than a specific, verifiable seal tied to the domain — a weaker signal than a badge served from LegitScript's own CDN.

§ NextMeds — Named Pharmacy, Unconfirmed Seal

ItemDetail
Compounding pharmacyFoothills Pharmacy, named,
Tirzepatide membership$179/mo, same at every dose,
LegitScript claimLinks only a generic search, unconfirmed,
: LegitScript link points only to a generic directory search, not a verifiable domain-specific seal.

What NextMeds is

NextMeds is a cash-pay telehealth platform, offering compounded semaglutide and tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a 1:1 care coach, and a licensed registered dietitian. It names its compounding pharmacy partner: Foothills Pharmacy.

What NextMeds costs

The standing membership runs $129/month for semaglutide and $179/month for tirzepatide — the same price at every dose, with no auto-renewal trap. The site displays promo-driven pricing with a countdown timer and "price increases" urgency messaging; the standing membership price above is what applies after any promo.

The brand-vs-compounded question

NextMeds dispenses compounded semaglutide and tirzepatide only — no brand-name Wegovy or Zepbound option, and it discloses this directly. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

NextMeds's real strengths,: a named compounding pharmacy (Foothills Pharmacy), a bundled flat membership covering medication, telehealth, a care coach, and a dietitian in one price, same price at every dose, free, no-obligation assessment before you pay anything, and FSA eligibility. The trade-offs: its LegitScript claim links only a generic directory search, not a verifiable seal, it uses promo-driven urgency messaging (countdown timers, "price increases") worth reading past, it's a technology platform coordinating care rather than the medical provider itself, with individual clinicians and a medical director not named, and it's compounded only. As with any GLP-1 program, and especially one with unconfirmed accreditation, ask directly about pharmacy verification before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

NextMeds's named compounding pharmacy and genuinely bundled membership — including a dietitian — are real positives, but its LegitScript claim doesn't hold up to scrutiny: the link behind it is a generic search, not a verifiable seal. For a provider with a genuinely CDN-verified LegitScript seal, compare it against NewSelf or CoreAge Rx. For another bundled-coaching provider with no LegitScript badge displayed at all, see NuDay Rx. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

Is NextMeds LegitScript certified?

Its site shows a LegitScript "approval" mention, but the link points only to a generic directory search rather than a verifiable seal tied to the domain — the claim is unconfirmed.

Does NextMeds name its compounding pharmacy?

Yes — Foothills Pharmacy.

How much does tirzepatide cost through NextMeds?

$109/month on the standing membership — the same price at every dose.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Related monograph sections

View all sections